UBS’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$7.79M Sell
73,102
-65,700
-47% -$6.81M 0.01% 1654
2014
Q2
$14.5M Buy
138,802
+26,402
+23% +$2.67M 0.01% 1089
2014
Q1
$11M Buy
112,400
+15,100
+16% +$1.4M 0.01% 1189
2013
Q4
$8.91M Sell
97,300
-55,700
-36% -$5.13M 0.01% 1343
2013
Q3
$13.3M Sell
153,000
-171,400
-53% -$15.4M 0.01% 933
2013
Q2
$27.9M Buy
+324,400
New +$27.5M 0.03% 505

Other funds holding JNJ

UBS's JNJ Position: Q3 2014 in Review

UBS increased its Johnson & Johnson (JNJ) stake by 7.2% in Q3 2014, buying an estimated $77.3M and bringing the position to 11,028,066 shares worth $1.18B. The position accounts for 0.87% of the portfolio, ranked #6.

UBS first reported a position in JNJ in Q2 2013 and has held it in 6 quarters since. 1,987 funds tracked by Wall St. Rank hold JNJ as of Q3 2014.

  • UBS held 11,028,066 shares of Johnson & Johnson worth $1.18B as of Q3 2014.
  • UBS bought 745,285 Johnson & Johnson shares in Q3 2014, an estimated $77.3M.
  • Johnson & Johnson made up 0.87% of UBS's portfolio in Q3 2014, its #6 holding.
  • UBS first reported a position in Johnson & Johnson in Q2 2013 and has held it in 6 quarters since.
  • 1,987 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.